Krystal Biotech Inc

Market cap: $4,981,480,899

Exchange: NAS

Sector: Health Technology

Share
Tweet

Krystal Biotech, Inc. is a gene therapy company, which engages in developing and commercializing treatment for patients suffering from dermatological diseases. It developed a gene therapy platform, which company refer to as the Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases for which company believe there are no known effective treatments. The company was founded by Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Key Statistics

Company Name

Krystal Biotech Inc

Average Volume (10 days)

341,777

Average Volume (30 days)

450,451

Moving Average (50 days)

$155.49

Moving Average (200 days)

$124.14

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

4,981,480,899

Shares Outstanding

28,292,616

52-Week High Split Adjust Only

189.97

52-Week Low Split Adjust Only

77.1

Employee Count

188

Beta

0.8007

Next Earnings Date

2024-05-06

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0.05%

Past 30 days

0.05%

Past 3 months

0.42%

Past 6 months

0.52%

Past year

1.2%

Past 2 years

1.49%

Past 5 years

4.34%

Max % Change

15.55%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Krystal Biotech IncKRYSn/an/a-18.9n/an/a
Peer AvgN/A3.32-1.07-10.53.324.06
Olema Pharmaceuticals IncOLMAn/an/a-21.2n/an/a
Omeros CorporationOMER13.27-4.27-7.713.2716.24
Oncocyte CorporationOCXn/an/a-13.1n/an/a
Oragenics Inc.OGENn/an/an/an/an/a